Skip to main content
Full access
Clinical and Research Reports
Published Online: 1 August 1999

Olanzapine for Psychosis in Patients With Parkinson's Disease With and Without Dementia

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences

Abstract

Twenty-one patients with Parkinson's disease and psychosis were included in an open-label 8-week trial of olanzapine. Eight subjects had dementia. Six subjects (29%) discontinued treatment prematurely because of drowsiness. Delusions and hallucinations improved significantly, and 80% were rated as much or very much improved. There was no worsening of parkinsonism or cognition.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 392 - 394
PubMed: 10440017

History

Published online: 1 August 1999
Published in print: August 1999

Authors

Details

D. Aarsland, M.D., Ph.D.
Received October 9, 1998; revised December 7, 1998; accepted January 14, 1999. From the Section of Geriatric Psychiatry, Rogaland Psychiatric Hospital, and the Department of Neurology, Central Hospital of Rogaland, Stavanger, Norway. Address correspondence to Dr. Aarsland, Section of Geriatric Psychiatry, Rogaland Psychiatric Hospital, P.O. Box 1163 Hillevåg, 4004 Stavanger, Norway. e-mail: [email protected]
J. P. Larsen, M.D., Ph.D.
Received October 9, 1998; revised December 7, 1998; accepted January 14, 1999. From the Section of Geriatric Psychiatry, Rogaland Psychiatric Hospital, and the Department of Neurology, Central Hospital of Rogaland, Stavanger, Norway. Address correspondence to Dr. Aarsland, Section of Geriatric Psychiatry, Rogaland Psychiatric Hospital, P.O. Box 1163 Hillevåg, 4004 Stavanger, Norway. e-mail: [email protected]
N. G. Lim , M.D.
Received October 9, 1998; revised December 7, 1998; accepted January 14, 1999. From the Section of Geriatric Psychiatry, Rogaland Psychiatric Hospital, and the Department of Neurology, Central Hospital of Rogaland, Stavanger, Norway. Address correspondence to Dr. Aarsland, Section of Geriatric Psychiatry, Rogaland Psychiatric Hospital, P.O. Box 1163 Hillevåg, 4004 Stavanger, Norway. e-mail: [email protected]
E. Tandberg, M.D.
Received October 9, 1998; revised December 7, 1998; accepted January 14, 1999. From the Section of Geriatric Psychiatry, Rogaland Psychiatric Hospital, and the Department of Neurology, Central Hospital of Rogaland, Stavanger, Norway. Address correspondence to Dr. Aarsland, Section of Geriatric Psychiatry, Rogaland Psychiatric Hospital, P.O. Box 1163 Hillevåg, 4004 Stavanger, Norway. e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share